Pattern of the Epitope-Specific IgG/IgM Response against Human Cytomegalovirus in Patients with Multiple Myeloma
Authors:
Open Access
- 1 August 2013
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 20 (8) , 1298-1304
Abstract
Human cytomegalovirus (HCMV) is a member of the herpesvirus family and represents a major human pathogen causing severe disease in newborns and immunocompromised patients, e.g., organ transplant recipients and patients with AIDS. One characteristic of herpesviruses is their ability to establish lifelong latency in their hosts; thus, reactivation during immunosuppression leads to recurrent episodes of disease. In several recent reports, it has been shown that HCMV infection may occur in patients with malignancy. This study focused on HCMV infection in patients with multiple myeloma (MM). In order to determine the IgM and IgG humoral immune response, sera from MM patients and healthy donors were analyzed with an accredited immunoblot test, and the IgM response was analyzed with an accredited enzyme-linked immunosorbent assay. A response against HCMV was detected in 80% of the MM patients. While the IgG pattern varied in each patient, the most prominent IgM response was against the tegument protein pp150 and two nonstructural proteins, the processivity factor (pUL44) and the single-stranded DNA binding protein (pUL57). An IgG avidity test revealed that 4 out of 20 MM patients had a fresh infection and 2 MM patients had a recent infection. The combination of IgG avidity and the IgM pattern will be a useful tool for reliable clinical diagnostics concerning HCMV and for application of early therapy for those MM patients suffering from a high viral load.Keywords
This publication has 17 references indexed in Scilit:
- Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survivalJournal of Clinical Virology, 2013
- National Prevalence Estimates for Cytomegalovirus IgM and IgG Avidity and Association between High IgM Antibody Titer and Low IgG AvidityClinical and Vaccine Immunology, 2011
- Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myelomaBlood, 2010
- Multiple myeloma: chemotherapy or transplantation in the era of new drugsEuropean Journal of Haematology, 2010
- Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple MyelomaJournal of Clinical Oncology, 2010
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastomaNeuro-Oncology, 2008
- Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003Journal of Clinical Oncology, 2007
- Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infectionsLeukemia & Lymphoma, 2006
- Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progressionFEMS Microbiology Reviews, 2004
- High Prevalence of Human Cytomegalovirus in Prostatic Intraepithelial Neoplasia and Prostatic CarcinomaJournal of Urology, 2003